Lotus (Nelumbo nucifera Gaertn.): A Comprehensive Reference
1. Identity
Botanical and Chemical Names
Nelumbo nucifera Gaertn., commonly known as lotus, sacred lotus, Indian lotus, water lily, or Chinese water lily, is an aquatic perennial crop belonging to the family Nelumbonaceae. The scientific name derives from a Sinhalese word for the plant (nelambu or nelum) and the Latin nucifera, meaning "nut-bearing," referring to the plant's edible, nut-like seeds. The species has also carried the synonyms Nymphaea nelumbo L. and Nelumbium speciosum in older literature. In Sanskrit the plant is called Padma (पद्म) or Kamala (कमल); it is one of two extant species of aquatic plant in the family Nelumbonaceae.
Natural Source and Distribution
Nelumbo nucifera manifests remarkable adaptability, characterized by its extensive distribution across varied climatic regions, underpinned by its robust rhizome system and prolific reproductive strategies. It is native to Asia and thrives in shallow waters such as ponds, marshes, and slow-moving rivers. Lotus plants are adapted to grow in the flood plains of slow-moving rivers and delta areas.
Plant Morphology and Edible Parts
The rhizomes are yellow, stout, and creeping; the fruits are green, and the leaves are large (20–90 cm in diameter) and are aerial as well as floating and orbicular. The flowers are approximately 10–25 cm in diameter, have many stamens, and come in colors ranging from pink to white. All parts of Nelumbo nucifera are edible, with the rhizome and seeds being the main consumption parts.
Common Forms and Preparations
Lotus is used in multiple forms in both traditional and commercial contexts. The rhizomes and seeds of Nelumbo nucifera are nutritionally significant, being rich sources of dietary fiber, essential vitamins, and minerals, and have found extensive culinary applications. All parts of lotus, including root, seed, seed pod, flower, and leaf, are used for ornamental and food purposes, including tea. Organic solvents including methanol, ethyl acetate, hexane, and n-butanol are widely employed for extraction of sacred lotus; seed embryo, flower stalk, stamen, old leaf, petal, and leaf stalk are also extracted using hot water (aqueous extraction). Commercial supplement forms include standardized leaf extracts (often standardized to nuciferine), seed powder capsules, dried leaf tea, and ethanolic or aqueous extracts used in functional foods and cosmetics.
2. Traditional and Historical Use
Cross-Cultural Overview
All parts of N. nucifera have been used for various medicinal purposes in various systems of medicine including folk medicines, Ayurveda, Chinese traditional medicine, and oriental medicine. Various parts of N. nucifera have been utilized as a vegetable as well as an herbal medicine for more than 2000 years in the Asian continent.
Ayurvedic Tradition (India)
Various parts of the lotus plant, from root to shoot, have documented use in different traditional systems of medicines, such as Indian traditional medicine (Ayurveda) and Chinese traditional medicine. Lotus has been in use since the times of Sushruta; the stalk was used as a probe in surgical procedures, while seeds, seed pods, and petals are used in Ayurveda treatment. The famous Ayurvedic medicine Aravindasavam is used in treating pediatric disorders. The botanical name is Nelumbo nucifera Gaertn., with Sanskrit synonyms including Kamal and Padma.
Traditional Chinese Medicine (TCM)
Traditionally, rhizomes, leaves, and seeds have been used as folk medicines, Ayurveda, Chinese traditional medicine, and oriental medicine; in Chinese medicine, seeds are still used as lian zi xin (蓮子心). Lotus plumule, the green embryo of lotus seeds, has been widely consumed as a tea by Asian people; as a traditional medicine, it is used for treating nervous disorders, insomnia, high fever with restlessness, and cardiovascular disease.
Traditional Preparations by Plant Part
Traditionally, the whole plant of lotus was used as astringent, emollient, and diuretic, and was used in the treatment of diarrhea, tissue inflammation, and homeostasis. The rhizome extract was used for antidiabetic and anti-inflammatory purposes due to the presence of steroidal triterpenoids; leaves were used as an effective drug for hematemesis, epistaxis, hemoptysis, hematuria, and metrorrhagia; flowers were used to treat diarrhea, cholera, fever, and hyperdipsia. The whole plant is used as antifungal, antipyretic, emollient, sudorific, diuretic, and cardiotonic.
Cultural and Symbolic Significance
Culturally, the lotus holds symbolic importance in numerous civilizations, depicted in art, religion, and literature. In Thailand, the sacred lotus has cultural importance as a spiritual symbol in Buddhism and economic importance as ornamentation and horticulture.
3. Key Constituents and Phytochemistry
Overview of Chemical Classes
Several bioactive compounds have been derived from lotus plant parts belonging to different chemical groups, including alkaloids, flavonoids, glycosides, triterpenoids, vitamins, etc., which all have their own therapeutic impact. Numerous bioactive components, including alkaloids, polyphenols, terpenoids, steroids, and glycosides, are responsible for its various biological and pharmacological activities.
Alkaloids
Alkaloids are the major secondary metabolites in lotus, accounting for approximately 2.43% of its dry weight. To date, 51 alkaloids, divided into four classes, have been identified, including 1-benzylisoquinoline, aporphines, bisbenzylisoquinolines, and tribenzylisoquinolines, with more than half belonging to the isoquinoline class.
Neferine, liensinine, isoliensinine, nuciferine, O-nornuciferine, dehydronuciferine, pronuciferine, and roemerine are recognized as key bioactive alkaloids present in Nelumbo nucifera.
- Nuciferine: Nuciferine is a monomeric aporphine alkaloid extracted from the leaves of Nelumbo nucifera. It has pharmacological activities including relaxing smooth muscles, improving hyperlipidemia, stimulating insulin secretion, vasodilation, inducing hypotension, antiarrhythmic effects, and antimicrobial and anti-HIV activities.
- Neferine: Neferine has antiarrhythmic effect and significantly inhibits platelet aggregation in rabbits; the antiarrhythmic potency of neferine has been demonstrated in several in vivo experimental studies.
- Liensinine and isoliensinine: Among the three major alkaloids, isoliensinine possesses the most potent cytotoxic effect, primarily by inducing apoptosis in triple-negative breast cancer cells through ROS generation and p38 MAPK/JNK activation.
- Higenamine (norcoclaurine): The flavonol miquelianin, as well as the alkaloids (+)-(1R)-coclaurine and (−)-(1S)-norcoclaurine, can be found in the leaves of N. nucifera. Higenamine is a natural β2-agonist of particular regulatory relevance (see Safety section).
Flavonoids
Lotus leaf flavonoid extract (LLFE) has been found to contain baicalein, kaempferol, kaempferid, quercetin, isorhamnetin, hyperoside, lespenephryl, and rutin. Lotus leaves are rich in polyphenols such as kaempferol and quercetin derivatives, polysaccharides, alkaloids such as nuciferine, N-nornuciferine, pronuciferine, steroids, and saponins.
Flavonoids in Flowers and Seedpods
The major phytochemicals present in the flowers of N. nucifera are quercetin, luteolin, luteolin glucoside, kaempferol, kaempferol-3-O-glucoside, and isoquercitrin. Lotus seedpods are rich in flavonoid compounds such as quercetin-3-glucuronide (Q3G), isorhamnetin-3-glucuronide, and isorhamnetin-3-glucoside.
Additional Compounds
Ferulic acid, coumarin, and chlorogenic acid are three dominant polyphenols found in lotus flower. The ethanolic extract of N. nucifera petals has been found to contain nine potent bioactive benzylisoquinoline alkaloids including (+)-juziphine, (+)-isococlaurine, (−)-N-methylisococlaurine, (−)-N-methylcoclaurine, (+)-nor-roefractine, (+)-armepavine, (−)-caaverine, (−)-lirinidine, and (+)-glaziovine.
4. Established and Proposed Mechanisms of Action
Anti-inflammatory Mechanisms
Lotus petal extracts exhibit immunomodulatory properties by suppressing TNF-α secretion in inflammatory-induced human macrophages by inhibiting NF-κB-dependent inflammatory response. Inhibition of the NF-κB inflammatory pathway was attributable to chlorogenic acid, rutin, ferulic acid, coumarin, quercetin, and kaempferol.
Antioxidant Mechanisms
Polyphenols exhibit antioxidant activity which leads to many health benefits. Lotus leaf flavonoid extract has been demonstrated to protect human hepatocytes from hydrogen peroxide-induced oxidative damage in cell-based models, acting through free-radical scavenging and protection against DNA damage.
Lipid-Lowering and Anti-Obesity Mechanisms
Modern pharmacological studies have shown that lotus leaf extract can reduce the digestive capacity of the body, reduce the absorption of lipids and carbohydrates, and regulate energy consumption so as to effectively improve hyperlipidemia and obesity. Proposed mechanisms include inhibition of lipase activity in the intestinal absorption phase, thereby reducing the hydrolysis and absorption of fat by the body. Lotus leaf extract has also been found to enhance lipolysis and induce a brown-fat gene expression signature and mitochondrial biogenesis in mesenchymal stem cells through activation of β3-AR/AMPK signaling.
Antidiabetic Mechanisms
Nuciferine has pharmacological activities including stimulating insulin secretion; these properties lay a foundation for the treatment of hyperglycemia. The rhizome extract was used as an antidiabetic due to the presence of steroidal triterpenoids.
Cardiovascular Mechanisms
The phytochemicals dauricine and neferine obtained from N. nucifera seeds have cardiovascular pharmacological effects; they blocked the Na⁺/K⁺ and Ca²⁺ cardiac transmembrane current. In guinea pig papillary muscles and atria, neferine at a dose of 0.1 mmol/L decreased the force of contraction, lowered the amplitude and Vmax of action potential (AP), and prolonged the action potential duration at 50% (APD50), action potential duration at 90% (APD90), and effective refractory period (ERP).
Neuroprotective Mechanisms
Lotus-derived alkaloids — particularly neferine, nuciferine, liensinine, and isoliensinine — exhibit antioxidant and anti-inflammatory effects, regulation of calcium signaling and ion channels, promotion of neurogenesis, and modulation of key neurotransmitter systems such as dopaminergic, cholinergic, and GABAergic pathways. They attenuate tau hyperphosphorylation, reduce oxidative stress-induced neuronal apoptosis, and enhance neurotrophic signaling via BDNF-related pathways.
Sleep-Promoting Mechanisms
Gamma-aminobutyric acid (GABA) present in lotus seeds was found to be a sleep-promoting compound that acts through the GABAA receptor. The sedative and anxiolytic effects of lotus alkaloids were confirmed through behavioral assays including open-field, light/dark box, and pentobarbital-induced sleep tests, with effects significantly attenuated by GABAA receptor antagonists; these findings suggest that lotus leaf alkaloids exert their central nervous system effects primarily via GABAergic and monoaminergic pathways, providing a pharmacological basis for their traditional use in promoting relaxation and improving sleep quality.
Anticancer Mechanisms
Neferine from Nelumbo nucifera inhibits cancer cell proliferation by inducing apoptosis; in lung cancer cells, neferine markedly inhibited A549 cell proliferation in a dose-dependent manner, and this autophagy was mediated through inhibition of PI3K/Akt/mTOR signaling. Induction of apoptosis, autophagy, and cell cycle arrest are the key pathways underlying the anticancer activity of neferine.
5. Scientific Evidence by Area of Health
5.1 Obesity and Body Weight Management
Preclinical evidence (animal and cell-based): Studies have systematically investigated the anti-obesity effect of lotus leaf extracts, finding that they reduce body weight, alleviate liver damage, and inhibit fat accumulation in high-fat-diet-induced obese mice. Lotus leaf extracts reduced serum ALT, AST, and AKP levels; decreased total cholesterol, triglycerides, and LDL-C; and increased HDL-C to improve dyslipidemia. Lotus leaves also inhibited inflammation accompanying obesity via decreasing IL-1β, TNF-α, IFN-γ, and IL-6 levels and increasing anti-inflammatory cytokines IL-4 and IL-10.
Treatment with ethanol extract of lotus root (ELR) in human pre-adipocytes resulted in inhibition of lipid accumulation and attenuated expression of adipogenic transcription factors such as PPARγ and adipocyte marker genes. Administration of ELR also resulted in a significant decrease in relative weights of adipose tissues in rats fed a high-fat diet, and decreased serum total cholesterol and triglyceride levels.
Human/clinical evidence: Evidence in humans is limited. A growing body of research indicates that lotus leaf can effectively reduce the absorption of dietary lipids and carbohydrates while modulating energy expenditure, thereby ameliorating hyperlipidemia and obesity; however, although its anti-obesity effects are acknowledged and have been applied in clinical practice, the underlying molecular mechanisms remain insufficiently elucidated. Controlled clinical trials in humans are sparse, and the overall human evidence base is preliminary.
5.2 Lipid Profile and Hyperlipidemia
Preclinical evidence: Nuciferine has been widely used in the treatment of ameliorating hyperlipidemia and weight loss and has been clinically used to treat hyperlipidemia and aid in weight loss due to its effects on lipid levels, insulin secretion, vasodilation, and blood pressure reduction.
Evidence from preclinical studies is substantial, showing consistent reduction in serum triglycerides and total cholesterol, and elevation of HDL cholesterol in animal models of high-fat diet-induced dyslipidemia. However, rigorous randomized controlled trials (RCTs) in humans specifically demonstrating lipid-lowering efficacy are not yet well-established in the peer-reviewed literature, and claims should be regarded as preliminary pending such evidence.
5.3 Diabetes and Glycemic Control
Preclinical evidence: Studies have investigated the antidiabetic and renoprotective effects of N. nucifera leaf extract (NLE) in a rat model of type 2 diabetes mellitus; male Sprague-Dawley rats with type 2 diabetes induced by high-fat diet/streptozotocin were treated with NLE at dosages of 0.5% and 1% (w/w) daily for 6 weeks, with assessment of serum glucose, insulin levels, and kidney function at the end of the experimental period.
Emerging clinical research: A registered randomized controlled trial is investigating the nutritional outcomes of lotus seed on diabetic sensorimotor polyneuropathy; participants receive the standard antidiabetic regimen with either placebo (starch) capsules at 200 mg/kg or lotus seed capsules at 200 mg/kg, with 60 subjects enrolled. This represents a formally registered intervention study, though results have not yet been widely published. The wealth of evidence from preclinical studies suggests that lotus holds promise as a natural therapeutic agent for managing metabolic disorders such as diabetes, obesity, and cardiovascular diseases. Overall, human clinical evidence for antidiabetic effects remains preliminary.
5.4 Cardiovascular Health
Preclinical evidence: Neferine has antiarrhythmic effects and significantly inhibits platelet aggregation in rabbits; its antiarrhythmic potency has been demonstrated in several in vivo experimental studies.
In a preclinical study in L-NAME-induced hypertensive rats, treatment with captopril (5 mg/kg) or a combination of lotus seed extract (LSE, 2.5 mg/kg) and captopril (2.5 mg/kg) effectively normalized systolic blood pressure to control level. Administration of LSE at doses of 5, 10, and 100 mg/kg significantly reduced hemodynamic parameters, while captopril alone or a combination of LSE (2.5 mg/kg) and captopril (2.5 mg/kg) fully restored them to normotensive level.
Human RCTs examining lotus for hypertension or arrhythmia are not yet identified in the peer-reviewed literature reviewed here. Evidence is at the preclinical stage.
5.5 Neuroprotection and Cognitive Function
Preclinical evidence: The neuroprotective effect of the embryo of lotus seeds was analyzed in HT22 cells through glutamate-induced cytotoxicity; seeds given to mice in different amounts ameliorated memory impairment and inhibited the activity of acetylcholinesterase. Neuroprotective effects were also associated with a decrease in ROS levels and intracellular accumulation of calcium.
Extractions from sacred lotus were analyzed for antioxidant and anti-Alzheimer's properties as key enzyme inhibitory activities toward acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and β-secretase 1 (BACE-1); the sacred lotus stamen exhibited significant amounts of phenolics that contributed to high antioxidant activity. Findings demonstrated that an aqueous extract of the stamen has potential for application as a functional food to mitigate the onset of Alzheimer's disease.
As of the current literature, formal human clinical trials on lotus for cognitive decline or dementia are not yet established. Evidence is preliminary and limited to in vitro and animal models.
5.6 Sleep and Anxiolytic Effects
Preclinical evidence: Studies have evaluated the sleep potentiating effects of water extract from lotus seed in rat using pentobarbital-induced sleep test and electroencephalogram (EEG) analysis to investigate sleep latency, duration, total sleeping time, and sleep quality; results strongly suggest that GABA contained in lotus seed extract acts as a sleep potentiating compound and that sleep-potentiating activity involves GABAA receptor binding.
Nelumbo nucifera seeds have been shown to increase phenobarbitone-induced sleep time and have confirmed anxiolytic action through light-dark model transitions and elevated zero maze tests in animal models. It has been reported that GABA and alkaloids contained in lotus seeds and leaves exert sedative and sleep effects via GABAA receptor binding.
Formal human sleep studies for lotus are not yet published in the sources reviewed. Evidence remains at the preclinical level.
5.7 Anti-inflammatory and Immunomodulatory Effects
In a cell-based study, human monocyte-derived macrophages were stimulated by lipopolysaccharide to mimic bacteria-induced inflammation. Lotus petal extracts showed high antioxidant capability and exhibited immunomodulatory properties by suppressing TNF-α secretion by inhibiting NF-κB-dependent inflammatory response.
Triterpenoid betulinic acid isolated from methanol extract of Nelumbo nucifera rhizome was evaluated for anti-inflammatory activity against edema in rat paw caused by carrageenan and serotonin. Methanol extract showed anti-inflammatory activity at doses of 200 and 400 mg/kg p.o.; betulinic acid demonstrated significant anti-inflammatory effect in inflammatory experimental models at doses of 50 mg/kg and 100 mg/kg p.o., producing similar effects to phenylbutazone and dexamethasone.
These studies are in vitro or rodent-based. No peer-reviewed human RCTs for anti-inflammatory outcomes were identified in the sources reviewed.
5.8 Cancer Biology
Within the past few decades, N. nucifera and its phytochemicals have been subjected to intense cancer research; peer-reviewed reviews have critically evaluated the potential of N. nucifera phytoconstituents in cancer prevention and therapy with related mechanisms of action.
Among the three major alkaloids, isoliensinine possesses the most potent cytotoxic effect, primarily by inducing apoptosis in triple-negative breast cancer cells through ROS generation and p38 MAPK/JNK activation.
All findings to date in oncology are from in vitro or animal studies. No human clinical trials for cancer treatment or prevention using lotus have been identified in the reviewed literature.
5.9 Hepatoprotective Effects
Network pharmacology results suggest that lotus root extract may play a role in the treatment of alcoholism by regulating neuroactive ligand-receptor interactions and biological processes including regulation of secretion and response to alcohol; animal experiments confirmed the therapeutic effect of lotus root on acute alcoholism through activation of alcohol catabolic enzymes, reduction of oxidative stress, and protection of liver function.
5.10 Antiviral Activity
Compounds including quercetin 3-O-β-D-glucuronide, coclaurine, and norcoclaurine isolated from Nelumbo nucifera leaves possessed therapeutic activity against HIV with EC50 values of 0.8 and <0.8 μg/mL and therapeutic index values of >125 and >25, respectively. Aporphine, benzylisoquinoline, and bisbenzylisoquinoline alkaloids (liensinine, isoliensinine, and neferine) isolated from leaves and embryo of lotus exhibited potent anti-HIV activities. These findings are in vitro only; no human antiviral clinical trials have been identified.
6. Body Systems Associated with Lotus
The whole plant, as well as crude extracts, fractions, and constituents, have been found to possess pharmacological activities including antioxidant, anti-inflammatory, immunomodulatory, antipyretic, antibacterial, antiviral, antifungal, antidiarrheal, diuretic, antiamnestic, antithrombotic, antiarrhythmic, antidiabetic, hypocholesterolemic, antiobesity, antiaging, antiatherosclerotic, antifibrotic, sedative, antineurodegenerative, memory-improving, antifertility, hepatoprotective, skin-protective, cardiovascular-protective, and anticancer properties.
- Cardiovascular system: Antiarrhythmic, antihypertensive, antithrombotic, lipid-lowering effects associated primarily with neferine, nuciferine, and dauricine.
- Metabolic/endocrine system: Antidiabetic, anti-obesity, lipid-modulating effects via PPARγ regulation, AMPK activation, and inhibition of pancreatic lipase and amylase.
- Central nervous system: Sedative, anxiolytic, neuroprotective, and memory-improving effects via GABAergic, dopaminergic, cholinergic, and serotonergic pathways.
- Gastrointestinal system: Antidiarrheal and digestive regulatory properties.
- Immune system: Immunomodulatory and anti-inflammatory activity via NF-κB pathway inhibition.
- Hepatic system: Hepatoprotective effects, including protection against oxidative stress and lipid accumulation in the liver.
- Renal system: Diuretic and nephroprotective activities documented in preclinical models.
7. Dosage Forms and Dosages Reported in Studies
Dosages for Nelumbo nucifera preparations vary widely by plant part, extract type, and research context. The following have been reported in peer-reviewed sources:
- Rhizome methanol extract (anti-inflammatory, rat): Anti-inflammatory activity at doses of 200 and 400 mg/kg p.o.
- Betulinic acid from rhizome (anti-inflammatory, rat): Significant anti-inflammatory effect at doses of 50 mg/kg and 100 mg/kg p.o.
- Lotus seed extract (hypertension, rat): LSE at doses of 5, 10, and 100 mg/kg significantly reduced hemodynamic parameters.
- Lotus seed capsules (human clinical trial, registered): Participants receive placebo capsules (starch) at the dose rate of 200 mg/kg or lotus seed capsules at a dose of 200 mg/kg.
- Nelumbo nucifera germ extract, oral (rat, NOAEL study): In a 4-week study in which rats were dosed orally with 25% Nelumbo Nucifera Germ Extract, the no-observed-adverse-effect-level (NOAEL) was 2500 mg/kg/d.
- Herbal mixture capsule containing N. nucifera (rat): A herbal mixture capsule containing 33% Nelumbo nucifera Gaertn. was orally administered at doses of 0, 1.44, or 4.32 g/kg/d to Wistar rats for 4 weeks; no gross lesions or size changes were observed in the heart, liver, lungs, or kidneys, and no significant histopathological differences were observed.
- Ethanolic lotus leaf extract (rodent, sleep): When the dose of the ethanolic lotus leaf extract was 300 mg/kg, it showed a significant difference compared to the normal group in the pentobarbital-induced sleep test.
- Quercetin-3-O-glucuronide (Q3G) from lotus leaf (sleep, rodent): To evaluate whether Q3G contributes to sleep enhancement, sleep latency and duration were measured; administration of 10 and 20 mg/kg Q3G showed a significant decrease in sleep latency.
Standardized human clinical dosages have not been established by regulatory or pharmacopoeial bodies as of the available literature.
8. Safety, Toxicology, and Notable Interactions
General Safety Profile
The safety profile of lotus leaf has been well established through numerous toxicological studies. Lotus (Nelumbo nucifera) is generally considered safe, with minimal adverse effects reported in animal studies, though rare mild liver and kidney changes may occur at high doses or with prolonged use.
Acute and Subchronic Toxicology
Since the use of Nelumbo nucifera stamens in herbal medicines and cosmetic products is highly prevalent, toxicity studies to confirm safe use are warranted; two toxicity studies have been performed to evaluate the safety of the ethanol extract of N. nucifera stamens, including an acute oral toxicity study at a very high dose and a repeated-dose 90-day oral toxicity study to establish the NOAEL.
No gross lesions or size changes were observed in the heart, liver, lungs, or kidneys, and no significant histopathological differences were observed in rats treated for 4 weeks with an herbal mixture capsule containing 33% N. nucifera.
Higenamine and WADA Prohibition
A significant and source-documented safety and regulatory concern pertains to higenamine, a naturally occurring β2-agonist alkaloid in lotus: since 2017, higenamine has been added to the World Anti-Doping Agency (WADA) prohibited list as a β2-agonist prohibited at all times for sportspersons, and according to WADA's report, positive cases of higenamine misuse have been increasing yearly.
Higenamine occurs naturally in the Chinese herb lotus plumule — the green embryo of lotus (Nelumbo nucifera Gaertn.) seeds — commercially available as concentrated powder on the Asian market. Higenamine was added to the WADA prohibited list in 2017 under the S3 category as a nonselective β2-agonist.
Lotus plumule consumption may engender adverse analytical findings regarding higenamine; athletes should avoid consuming lotus plumule-containing products during in- and out-of-competition periods.
Unclear or missing labeling of ingredients in commercial products has caused several cases of assumed inadvertent doping; LC-MS analysis of different preparations neither listing higenamine nor relevant plant extracts on their label yielded the alkaloid at concentrations of 0.02–14 mg/g.
Allergic Reactions
Side effects appear to be rare, but lotus might cause allergic reactions such as skin itching in some people.
Potential Drug Interactions and Special Populations
Due to its pharmacologically active alkaloid content (particularly nuciferine's documented effects on smooth muscle, blood pressure, and insulin secretion), lotus preparations carry a theoretical potential for interaction with antihypertensive drugs, insulin secretagogues, and cardiac medications. However, formal human drug interaction studies are not yet available in the peer-reviewed literature. Preliminary evidence supports that lotus is promising for mild anxiety and digestion, but the plant is not demonstrated to be a panacea for every ailment, and traditional claims should be cross-checked.
Evidence Gaps and Limitations
The overwhelming majority of pharmacological research on Nelumbo nucifera has been conducted in vitro or in rodent models. While both traditional use and modern studies underscore the broad pharmacological potential of Nelumbo nucifera, most contemporary research has concentrated on its anti-cancer and cardioprotective effects. Formal, adequately powered, peer-reviewed randomized controlled trials in humans are scarce across all proposed indications. Standardized preparations, bioavailability data, and pharmacokinetic profiles in humans remain incompletely characterized in the published literature.
References
Go back